ADOCAdocia SA
4.152EUR+1.02%Mkt Cap: 91.59M $P/E:

Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic pr…

Key Statistics

Company
Market Cap91.59M $
Enterprise Value78.58M $
Revenue (TTM)4.18M $
Gross Profit742.39K $
Net Income (TTM)-18.03M $
Revenue/Share0.2337 USD
Last Price4.152 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees73
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.58
PEG
EV/EBITDA-4.74
EV/Revenue18.79
P/S21.65
P/B54.24
EPS (TTM)-1.00
EPS (Forward)-7.10
52W Range
3.6106% of range12.40
52W High12.40 EUR
52W Low3.610 EUR
Profitability
Gross Margin46.31%
Oper. Margin-414.19%
EBITDA Margin0.00%
Profit Margin-1124.81%
ROE-1112.74%
ROA-58.31%
Growth
Revenue Growth-84.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-7.10M $
CapEx (TTM)290.22K $
FCF Margin-13.57%
FCF Yield-0.62%
Net Debt-9.08M $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity5.97
Current Ratio1.19
Quick Ratio1.14
Book Value/Sh0.0760 EUR
Cash/Share0.8820 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)9.700 EUR
Upside (mean)+133.6%
Target Range4.800 EUR12.00 EUR
4.800+133.6% to mean12.00
# Analysts4
Ownership
Shares Out.20.21M
Float16.27M
Insiders6.75%
Institutions7.92%
Technical
SMA 504.051 (+2.5%)
SMA 2005.524 (-24.8%)
Beta0.27
S&P 52W Chg18.16%
Avg Vol (30d)70.33K
Avg Vol (10d)89.19K
Technical Indicators
RSI (14)51.8
MACD0.0442
MACD Signal0.0277
MACD Hist.+0.0165
BB Upper4.287 EUR
BB Middle4.064 EUR
BB Lower3.842 EUR
BB Width10.93%
ATR (14)0.1452 EUR
Vol Ratio (20d)1.43x